








|
Quality Unit Services
Quality Systems:
 | GxP (GMP, GLP, GCP), GAMP, and QSR regulation consultation,
strategy and gap analyses |
 | Development of customized Corporate Quality Systems Master Plans,
including integration with any client desired elements related to universal
quality enhancement principles such as
 |
CQI, ISO, TQM, six sigma |
|
 |
Quality and Technology Integration planning
focusing on the technology platform(s) and quality/compliance goals of the
individual client |
 |
Compliance Enhancement Programs for drugs, biologics, devices, and combination products |
 | CAPA System development and/or tracking execution |
Quality Assurance:
 |
Planning and execution of Quality Assurance Review projects such
as
 | Contract
Manufacturer or internal batch records (including manufacturing, testing and
labeling/packaging), validation protocols/ reports and GxP
development reports |
|
 |
Standard Operating Procedure (SOP) and Change Control system development
and implementation
 |
Master Documentation development for manufacturing and testing |
 | SOP writing |
|
 |
Training program development and providing on-site or
distance training courses
 |
training system and information tracking |
|
Quality Control:
 |
Implementation and evaluation Quality Control (laboratory) systems
 |
Identification, set-up and/or management of Contract
Laboratories (GxP) |
|
 |
Development, evaluation and/or execution of Stability
programs |
 | Validation services for methods and equipment |
 | Product trouble-shooting and investigation |
Quality Management:
 |
Supplier Quality Agreement negotiation on behalf of clients |
 | Quality Project Management of GxP Contract Service
Providers to meet client requirements |
 |
Technical writing and/or review for communications with regulatory agencies, including
INDs, NDAs, BLAs, DMFs, and annual reports |
Quality/compliance:
 |
Internal and external Supplier Audits according to US and EU regulatory requirements and/or unique client requirements |
 |
Remediation Programs (e.g. for required actions related to FDA Form 483, warning
letters and consent decrees) |
 |
Mock inspections including the use of team-based approaches
with technical specialists to cover the area(s) of interest to the client |
|
|